Cefiderocol as Rescue Therapy for <i>Acinetobacter baumannii</i> and Other Carbapenem-resistant Gram-negative Infections in Intensive Care Unit Patients

Marco Falcone, Giusy Tiseo, Manuela Nicastro, Alessandro Leonildi, Alessandra Vecchione, Costanza Casella, Francesco Forfori, P Malacarne, Fabio Guarracino, Simona Barnini,

Clinical Infectious Diseases · 2020 · 136 citations · 7 references

Concepts

Abstract

Ten critically ill patients with either bacteremia or ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii, Stenotrophomonas maltophilia, or New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae received cefiderocol. All strains had minimum inhibitory concentration ≤2 μg/mL. Thirty-day clinical success and survival rates were 70% and 90%, respectively. Two patients had a microbiological failure. Future prospective studies are warranted.

References

7